Note: Ingredients listed on restricted chemical lists
EC/CAS
215-171-9/1309-48-4
Name of the chemical
magnesium oxide
Concentration
>= 10 - <= 15
General Information
Version
6.0
Revision date
2023-02-03
Product name
OPTI-PK 0-11-21
Product name
OPTI-PK 0-11-21
Identification on the label/Trade name
Giftinformasjonen (Poison Center)
1.2.1 Relevant identified uses
Industrial distribution
Emergency telephone
+47 21 03 44 52
Icons in SDS
Company Information
company name
Yara Norge AS
e-mail address of the competent person responsible for the Safety Data Sheet
sds.landbruk@yara.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H318
Hazard statements
Code
Statements
H318
Causes serious eye damage
Section 2
SECTION 2: Hazards identification
1272/2008] Classification of the substance or mixture
Product definition
Mixture
Signal word
Danger
Hazard statements
H318 Causes serious eye damage.
Prevention
P280 Wear protective gloves and eye protection.
Response
P305 IF IN EYES: P351 Rinse cautiously with water for several minutes. P338 Remove contact lenses, if present and easy to do. Continue rinsing. P310 Immediately call a POISON CENTER or doctor/physician.
Hazardous Ingredients
Potassium sulfate Triple superphosphates Superphosphates EU Regulation (EC) No. Not applicable.
Special packaging requirements
Containers to be fitted with Not applicable. child-resistant fastenings
Tactile warning of danger
Not applicable.
2.3 Other hazards
Product meets the This mixture does not contain any substances that are assessed to be a criteria for PBT or vPvB PBT or a vPvB. according to Regulation (EC) No.
Other hazards which do not result in classification
None known.
Additional information
Product forms slippery surface when combined with water.
2.1 Classification of the substance or mixture
Product definition : Mixture Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS] Classification : Eye Dam. 1, H318 The product is classified as hazardous according to Regulation (EC) 1272/2008 as amended. See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.
